Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Enzastaurin|DRUG: Bevacizumab|DRUG: Paclitaxel|DRUG: Placebo
Sponsor: Eli Lilly and Company
Collaborators: Genentech, Inc.